Medtronic Launches New Clinical Trials to Expand Hugo RAS System Indications into Hernia and Gynecology
Medtronic
Chronic Disease Medical Device and Therapy Developer
Pioneer in Medical Device Media Reports
Share Professional Medical Device Knowledge
The company stated that these studies are ongoing to support the planned submission to the FDA for the Hugo RAS system, as Medtronic continues to build momentum outside of the United States.
Medtronic Pins High Hopes on Hugo
Hernia Repair U.S. Clinical Trial Begins with Robot-Assisted Bilateral Inguinal Hernia Repair at Duke University Hospital in Durham, North CarolinaIts lead researcher, Dr. Jacob Greenberg, carried out this series of implementations. "Our team is dedicated to exploring new technologies to enhance patient care," said Dr. Greenberg at a press conference. "This clinical trial aims to evaluate a new robotic-assisted surgical system, offering precise and minimally invasive options for this painful condition that affects millions of Americans each year."
Mike Marinaro, Executive Vice President of Medtronic's Medical Surgical Portfolio, said on the company's fourth-quarter earnings call: "[This] is important. We are now conducting clinical trials across multiple indications so that when we enter the market, we can have a series of launches for each indication to gain an increasing share of the market. We are seeing good execution, and the early execution of these studies is also promising."
This clinical trial is a prospective, multi-center study designed to evaluate the safety and performance of the Hugo RAS to support the FDA submission. MedtronicUROThe expanded clinical trial in urology is nearing completion. Medtronic has also initiated a prospective clinical study in gynecological surgery to support the submission plan to the FDA.
"Medtronic is committed to providing safe and effective healthcare technologies to help clinicians improve patient care," said Eric Vang, Vice President of Clinical Research and Medicine for the Surgical Business within Medtronic's Medical Surgical Portfolio. "Hugo upholds this commitment by combining the power and potential of people and technology to advance healthcare for all."
The Hugo RAS system is not approved or recognized in all markets. In the United States, the Hugo RAS system is a research device and has not been put on sale.
According to Medtronic, robot-assisted surgery can reduce patient complications, shorten hospital stays, and enable faster return to normal activities.
Through collaboration with surgeons and hospitals, Medtronic designed the Hugo RAS to expand access to minimally invasive care for more patients worldwide.
Hugo is a modular multi-quadrant platform designed with wristed instruments, 3D visualization, and surgical video capture options for various surgical procedures in Touch Surgery Enterprise.
Medtronic's entry into the soft tissue robotic-assisted surgery field represents a significant growth opportunity for Medtronic, as well as for Intuitive Surgical, which currently dominates the soft tissue robotic surgery market, as it signifies an expanding market. In recent years, multiple medical technology companies have also entered the surgical robotics market hoping to compete with Intuitive. Intuitive has held the leading position in surgical robotics for over 20 years and shows no signs of slowing down. In orthopedics, Stryker launched the Mako Surgical Robot for hip and knee replacements and plans to expand its applications to shoulder and spine procedures.Zimmer BiometLaunched its own orthopedic surgery robot ROSA for total knee replacement.
Surgical robots for soft tissue applications and endoscopic surgeries are also on the rise. In 2019, Johnson & Johnson Medical Technologies acquiredAuris HealthAnd surgical robots used in bronchoscopy diagnosis and treatment processes. Case CMR Surgical's Versius robotic system spans over 130 types of complex and benign surgeries as the UK-based company expands outside the US. Versius performs colectomies, hernia repairs, hysterectomies, sacrocolpopexies, and lobectomies across seven surgical specialties.
Many other medical technology companies, such as Moon Surgical, SS Innovations, Noah Medical, Corin Group, etc., are developing surgical robots. Thus, it is a highly competitive market.
More exciting content
Welcome to follow WeChat Video Channel
Tomorrow, Medtronic to Lay Off All Employees
Over 50,000 Units, Imaging Giant Issues Level-One Recall
"The Strongest Husband-and-Wife Team in the Medical Device Industry" Is Going IPO Again
"King of Imaging in County Towns" Passes HKEX Hearing
2023 Medical Device Industry Salary Ranking: Mindray First
Just now, the Shenzhen Stock Exchange inquired about this medical device company
Worry-Free Listening, Always Ahead: Cochlear Launches the All-In-One Sound Processor Kanso™ in China
Instrument Family: Top 10 Innovative Surgical Robot Products of 2024
The World's Largest Private Medical Device Manufacturer: Layoffs and Plant Closures
What's the Outcome? Philips Sues "Largest Third-Party"
BusinessBusiness cooperation email: qxzj@landianyiliao.com
